1. Executive Summary 2. Coronavirus (COVID-19) - Introduction, Pathogen Characteristics, Signs and Symptoms, Transmission and Prevention 2.1 Introduction 2.2 Pathogen Characteristics 2.3 Signs and Symptoms 2.4 Transmission 2.5 Prevention 3. Funding in the Coronavirus (COVID-19) Vaccine Research 4. Vaccines Developed Against MERS-CoV 5. Vaccines Developed Against SARS-CoV 6. Coronavirus (COVID-19) Vaccine Clinical Trial Insights by Phase, Company and Country 7. Countries, Territories or Areas with Reported Laboratory-Confirmed Coronavirus (COVID-19) Cases and Deaths 8. Major Partnership and Collaboration Deals in the Coronavirus (COVID – 19) Vaccine Market 8.1 Collaboration Deals 8.2 Partnership Deals 9. Key Vaccine Developers Analysis 9.1 University of Oxford 9.1.1 Business Overview 9.1.2 Promising Coronavirus Vaccines in the Clinical Development 9.1.3 Recent Development 9.2 Clover Biopharmaceuticals/Dynavax/GlaxoSmithKline 9.2.1 Business Overview 9.2.2 Promising Coronavirus Vaccines in the Clinical Development 9.2.3 Recent Development 9.3 Heat Biologics Inc./University of Miami 9.3.1 Business Overview 9.3.2 Promising Coronavirus Vaccines in the Clinical Development 9.3.3 Recent Development 9.4 Inovio Pharmaceuticals Inc 9.4.1 Business Overview 9.4.2 Promising Coronavirus Vaccines in the Clinical Development 9.4.3 Recent Development 9.5 Janssen Pharmaceutical 9.5.1 Business Overview 9.5.2 Promising Coronavirus Vaccines in the Clinical Development 9.5.3 Recent Development 9.6 Sanofi Pasteur/GlaxoSmithKline (GSK) 9.6.1 Business Overview 9.6.2 Promising Coronavirus Vaccines in the Clinical Development 9.6.3 Recent Development 9.7 Moderna/NIAID 9.7.1 Business Overview 9.7.2 Promising Coronavirus Vaccines in the Clinical Development 9.7.3 Recent Development 9.8 Novavax 9.8.1 Business Overview 9.8.2 Promising Coronavirus Vaccines in the Clinical Development 9.8.3 Recent Development 9.9 Sanofi Pasteur/Translate Bio Inc. 9.9.1 Business Overview 9.9.2 Promising Coronavirus Vaccines in the Clinical Development 9.9.3 Recent Development 9.10 Vaxart Inc. 9.10.1 Business Overview 9.10.2 Promising Coronavirus Vaccines in the Clinical Development 9.10.3 Recent Development 9.11 Altimmune 9.11.1 Business Overview 9.11.2 Promising Coronavirus Vaccines in the Clinical Development 9.11.3 Recent Development 9.12 Medicago 9.12.1 Business Overview 9.12.2 Promising Coronavirus Vaccines in the Clinical Development 9.12.3 Recent Development 9.13 BioNTech/Pfizer/Fosun Pharma 9.13.1 Business Overview 9.13.2 Promising Coronavirus Vaccines in the Clinical Development 9.13.3 Recent Development 9.14 GeoVax/BravoVax 9.14.1 Business Overview 9.14.2 Promising Coronavirus Vaccines in the Clinical Development 9.14.3 Recent Development 9.15 Arcturus Therapeutics/Duke-NUS 9.15.1 Business Overview 9.15.2 Promising Coronavirus Vaccines in the Clinical Development 9.15.3 Recent Development 9.16 CanSino Biological Inc/Beijing Institute of Biotechnology 9.16.1 Business Overview 9.16.2 Promising Coronavirus Vaccines in the Clinical Development 9.16.3 Recent Development 9.17 Takis Biotech/Applied DNA Sciences/Evvivax 9.17.1 Business Overview 9.17.2 Promising Coronavirus Vaccines in the Clinical Development 9.17.3 Recent Development 9.18 Cobra Biologics/Karolinska Institute 9.18.1 Business Overview 9.18.2 Promising Coronavirus Vaccines in the Clinical Development 9.18.3 Recent Development 9.19 Zydus Cadila 9.19.1 Business Overview 9.19.2 Promising Coronavirus Vaccines in the Clinical Development 9.19.3 Recent Development 9.20 Codagenix/Serum Institute of India 9.20.1 Business Overview 9.20.2 Promising Coronavirus Vaccines in the Clinical Development 9.20.3 Recent Development 9.21 Greffex 9.21.1 Business Overview 9.21.2 Promising Coronavirus Vaccines in the Clinical Development 9.21.3 Recent Development 9.22 ExpreS2ion Biotechnologies ApS 9.22.1 Business Overview 9.22.2 Promising Coronavirus Vaccines in the Clinical Development 9.22.3 Recent Development 9.23 Vaxil Bio Therapeutics 9.23.1 Business Overview 9.23.2 Promising Coronavirus Vaccines in the Clinical Development 9.23.3 Recent Development 9.24 Flow Pharma Inc 9.24.1 Business Overview 9.24.2 Promising Coronavirus Vaccines in the Clinical Development 9.24.3 Recent Development 9.25 AJ Vaccines 9.25.1 Business Overview 9.25.2 Promising Coronavirus Vaccines in the Clinical Development 9.25.3 Recent Development 9.26 Generex Biotechnology/EpiVax 9.26.1 Business Overview 9.26.2 Promising Coronavirus Vaccines in the Clinical Development 9.26.3 Recent Development 9.27 Immunomic Therapeutics/EpiVax/PharmaJet 9.27.1 Business Overview 9.27.2 Promising Coronavirus Vaccines in the Clinical Development 9.27.3 Recent Development 9.28 iBio Inc/CC-Pharming Ltd/Infectious Disease Research Institute 9.28.1 Business Overview 9.28.2 Promising Coronavirus Vaccines in the Clinical Development 9.28.3 Recent Development 9.29 VIDO-InterVac/University of Saskatchewan/International Vaccine Institute 9.29.1 Business Overview 9.29.2 Promising Coronavirus Vaccines in the Clinical Development 9.29.3 Recent Development 9.30 Tonix Pharmaceuticals/Southern Research 9.30.1 Business Overview 9.30.2 Promising Coronavirus Vaccines in the Clinical Development 9.30.3 Recent Development 9.31 IAVI/Batavia Biosciences 9.31.1 Business Overview 9.31.2 Promising Coronavirus Vaccines in the Clinical Development 9.31.3 Recent Development 9.32 Curevac 9.32.1 Business Overview 9.32.2 Promising Coronavirus Vaccines in the Clinical Development 9.32.3 Recent Development 9.33 Imophoron Ltd/University of Bristol 9.33.1 Business Overview 9.33.2 Promising Coronavirus Vaccines in the Clinical Development 9.33.3 Recent Development 9.34 BioNet Asia 9.34.1 Business Overview 9.34.2 Promising Coronavirus Vaccines in the Clinical Development 9.34.3 Recent Development 9.35 Sinovac/Dynavax 9.35.1 Business Overview 9.35.2 Promising Coronavirus Vaccines in the Clinical Development 9.35.3 Recent Development 9.36 BIOCAD 9.36.1 Business Overview 9.36.2 Promising Coronavirus Vaccines in the Clinical Development 9.36.3 Recent Development 9.37 University of Pittsburgh 9.37.1 Business Overview 9.37.2 Promising Coronavirus Vaccines in the Clinical Development 9.37.3 Recent Development

Table 4–1: Vaccines Developed Against MERS-CoV Table 5–1: Vaccines Developed Against SARS-CoV Table 7–1: Countries, Territories or Areas with Reported Laboratory-Confirmed Coronavirus (COVID-19) Cases and Deaths Table 9–1: University of Oxford Promising Coronavirus Vaccines in the Clinical Development Table 9–2: Clover Biopharmaceuticals/Dynavax/GSK Promising Coronavirus Vaccines in the Clinical Development Table 9–3: Heat Biologics Inc/University of Miami Promising Coronavirus Vaccines in the Clinical Development Table 9–4: Inovio Pharmaceuticals Inc Promising Coronavirus Vaccines in the Clinical Development Table 9–5: Janssen Pharmaceutical Promising Coronavirus Vaccines in the Clinical Development Table 9–6: Sanofi Pasteur/GlaxoSmithKline (GSK) Promising Coronavirus Vaccines in the Clinical Development Table 9–7: Moderna/NIAID Promising Coronavirus Vaccines in the Clinical Development Table 9–8: Novavax Promising Coronavirus Vaccines in the Clinical Development Table 9–9: Sanofi/Translate Bio Promising Coronavirus Vaccines in the Clinical Development Table 9–10: Vaxart Inc. Promising Vaccines in the Clinical Development Table 9–11: Altimmune Promising Coronavirus Vaccines in the Clinical Development Table 9–12: Medicago Promising Coronavirus Vaccines in the Clinical Development Table 9–13: BioNTech/Pfizer/Fosun Pharma Promising Coronavirus Vaccines in the Clinical Development Table 9–14: GeoVax/BravoVax Promising Coronavirus Vaccines in the Clinical Development Table 9–15: Arcturus Therapeutics/Duke-NUS Promising Coronavirus Vaccines in the Clinical Development Table 9–16: CanSino Biological Inc/ Beijing Institute of Biotechnology Promising Coronavirus Vaccines in the Clinical Development Table 9–17: Takis/Applied DNA Sciences/Evvivax Promising Coronavirus Vaccines in the Clinical Development Table 9–18: Cobra Biologics/ Karolinska Institute Promising Coronavirus Vaccines in the Clinical Development Table 9–19: Zydus Cadila Promising Coronavirus Vaccines in the Clinical Development Table 9–20: Codagenix/Serum Institute of India Promising Coronavirus Vaccines in the Clinical Development Table 9–21: Greffex Promising Coronavirus Vaccines in the Clinical Development Table 9–22: ExpreS2ion Biotechnologies ApS Promising Coronavirus Vaccines in the Clinical Development Table 9–23: Vaxil Bio Therapeutics Promising Coronavirus Vaccines in the Clinical Development Table 9–24: Flow Pharma Inc Promising Coronavirus Vaccines in the Clinical Development Table 9–25: AJ Vaccines Promising Coronavirus Vaccines in the Clinical Development Table 9–26: Generex Biotechnology/EpiVax Promising Coronavirus Vaccines in the Clinical Development Table 9–27: Immunomic Therapeutics, EpiVax & PharmaJet Promising Coronavirus Vaccines in the Clinical Development Table 9–28: iBio/CC-Pharming/IDRI Promising Coronavirus Vaccines in the Clinical Development Table 9–29: VIDO-InterVac/University of Saskatchewan/IVI Promising Coronavirus Vaccines in the Clinical Development Table 9–30: Tonix Pharmaceuticals/Southern Research Promising Coronavirus Vaccines in the Clinical Development Table 9–31: IAVI/Batavia Biosciences Promising Coronavirus Vaccines in the Clinical Development Table 9–32: Curevac Promising Coronavirus Vaccines in the Clinical Development Table 9–33: Imophoron Ltd/University of Bristol Promising Coronavirus Vaccines in the Clinical Development Table 9–34: BioNet Asia Promising Coronavirus Vaccines in the Clinical Development Table 9–35: Sinovac/Dynavax Promising Coronavirus Vaccines in the Clinical Development Table 9–36: BIOCAD Promising Coronavirus Vaccines in the Clinical Development Table 9–37: University of Pittsburgh Promising Coronavirus Vaccines in the Clinical Development